Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiora Pharmaceuticals (KPRX) Non Operating Income (2016 - 2025)

Kiora Pharmaceuticals (KPRX) has disclosed Non Operating Income for 11 consecutive years, with $178114.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non Operating Income rose 397.21% year-over-year to $178114.0, compared with a TTM value of $723330.0 through Sep 2025, up 140.86%, and an annual FY2024 reading of $1.1 million, up 3885.47% over the prior year.
  • Non Operating Income was $178114.0 for Q3 2025 at Kiora Pharmaceuticals, up from -$93556.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $655025.0 in Q4 2024 and bottomed at -$194116.0 in Q4 2023.
  • Average Non Operating Income over 5 years is $84768.5, with a median of $4428.0 recorded in 2022.
  • The sharpest move saw Non Operating Income soared 11182.28% in 2023, then crashed 156.69% in 2024.
  • Year by year, Non Operating Income stood at -$3832.0 in 2021, then skyrocketed by 124.45% to $937.0 in 2022, then crashed by 20816.76% to -$194116.0 in 2023, then skyrocketed by 437.44% to $655025.0 in 2024, then plummeted by 72.81% to $178114.0 in 2025.
  • Business Quant data shows Non Operating Income for KPRX at $178114.0 in Q3 2025, -$93556.0 in Q2 2025, and -$16253.0 in Q1 2025.